Aurora Cannabis (TSE:ACB) Stock Price Up 0.8% – What’s Next?

Aurora Cannabis Inc. (TSE:ACB)’s share price rose 0.8% during mid-day trading on Monday . The stock traded as high as C$5.15 and last traded at C$5.08. Approximately 431,950 shares were traded during trading, an increase of 17% from the average daily volume of 368,761 shares. The stock had previously closed at C$5.04.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group set a C$10.00 price target on shares of Aurora Cannabis and gave the stock a “buy” rating in a research note on Tuesday, January 27th. Two investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of C$9.25.

Aurora Cannabis Price Performance

The company has a market capitalization of C$300.37 million, a price-to-earnings ratio of -3.39 and a beta of 0.40. The company’s 50 day simple moving average is C$4.83 and its 200-day simple moving average is C$5.88. The company has a current ratio of 3.06, a quick ratio of 2.48 and a debt-to-equity ratio of 25.02.

Aurora Cannabis (TSE:ACB) last released its quarterly earnings results on Wednesday, February 4th. The company reported C$0.03 earnings per share (EPS) for the quarter. Aurora Cannabis had a negative net margin of 1.69% and a negative return on equity of 1.15%. The company had revenue of C$94.19 million for the quarter. On average, equities research analysts predict that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.